4-Amino-6-hydroxypyrazolo [3,4-d]pyrimidine (AHPP) conjugated PEG micelles: Water soluble polymeric xanthine oxidase inhibitor

References

• Adachi T, Fukushima T, Usami Y, Hirano K. (1993). Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J, 289 (Pt 2), 523–527.
   PubMed Web of Science ®Google Scholar
• Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marbán E, Hare JM. (2001). Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation, 104, 2407–2411.
   PubMed Web of Science ®Google Scholar
• Crow JP, Beckman JS. (1995). The role of peroxynitrite in nitric oxide-mediated toxicity. In: Koprowski H, Maeda H. (eds.). The Role of Nitric Oxide in Physiology and Pathophysiology. Current Topics in Microbiology and Immunology. Springer-Verlag, Berlin 196:57–73.
   Google Scholar
• Donald LJ, Robert A, Mercedes C, Giovanni DS, Ferguson TB, Flegal K, Ford E, Furie K, Alan G, Greenlund K, Haase N, Hailpern S, Michael H, Howard V, Kissela B, Kittner S, Lackland D, Lisabet, L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O’Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. (2009). Heart Disease and Stroke Statistics_2009. Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:e21–e181.
   PubMed Web of Science ®Google Scholar
• Duncan R. (2003). The dawning era of polymer therapeutics. Nat Rev Drug Discov, 2, 347–360.
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Khaled G, Hamada A, Maeda H. (2003). In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res, 63, 3567–3574.
   PubMed Web of Science ®Google Scholar
• Fang J, Iyer AK, Seki T, Nakamura H, Greish K, Maeda H. (2009a). SMA-copolymer conjugate of AHPP: a polymeric inhibitor of xanthine oxidase with potential antihypertensive effect. J Control Release, 135, 211–217.
   PubMed Web of Science ®Google Scholar
• Fang J, Seki T, Maeda H. (2009b). Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev, 61, 290–302.
   PubMed Web of Science ®Google Scholar
• Feigelson P, Davidson JD, Robins RK. (1957). Pyrazolopyrimidines as inhibitors and substrates of xanthine oxidase. J Biol Chem, 226, 993–1000.
   PubMed Web of Science ®Google Scholar
• Freehold NJ. (1972). Xanthine Oxidase (milk). In: Worthington Enzyme Manual. Worthington Biochemical, pp. 30–31.
   Google Scholar
• Greish K, Sawa T, Fang J, Akaike T, Maeda H. (2004). SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours. J Control Release, 97, 219–230.
   PubMed Web of Science ®Google Scholar
• Greish K, Nagamitsu A, Fang J, Maeda H. (2005). Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity. Bioconjug Chem, 16, 230–236.
   PubMed Web of Science ®Google Scholar
• Gryglewski RJ, Palmer RM, Moncada S. (1986). Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 320, 454–456.
   PubMed Web of Science ®Google Scholar
• Harada A, Kataoka K. (1999). Chain length recognition: core-shell supramolecular assembly from oppositely charged block copolymers. Science, 283, 65–67.
   PubMed Web of Science ®Google Scholar
• Huie RE, Padmaja S. (1993). The reaction of No with superoxide. Free Radic Res Commun, 18, 195–199.
   PubMed Web of Science ®Google Scholar
• Ideta R, Tasaka F, Jang WD, Nishiyama N, Zhang GD, Harada A, Yanagi Y, Tamaki Y, Aida T, Kataoka K. (2005). Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nano Lett, 5, 2426–2431.
   PubMed Web of Science ®Google Scholar
• Iyer AK, Khaled G, Fang J, Maeda H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today, 11, 812–818.
   PubMed Web of Science ®Google Scholar
• Iyer AK, Greish K, Seki T, Okazaki S, Fang J, Takeshita K, Maeda H. (2007a). Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation. J Drug Target, 15, 496–506.
   PubMed Web of Science ®Google Scholar
• Iyer AK, Greish K, Fang J, Murakami R, Maeda H. (2007b). High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor. Biomaterials, 28, 1871–1881.
   PubMed Web of Science ®Google Scholar
• Jarasch ED, Bruder G, Heid HW. (1986). Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand Suppl, 548, 39–46.
   PubMedGoogle Scholar
• Jarasch ED, Grund C, Bruder G, Heid HW, Keenan TW, Franke WW. (1981). Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell, 25, 67–82.
   PubMed Web of Science ®Google Scholar
• Maeda H. (2001a). SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev, 46, 169–185.
   PubMed Web of Science ®Google Scholar
• Maeda H. (2001b). The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul, 41, 189–207.
   PubMedGoogle Scholar
• Maeda H, Sawa T, Konno T. (2001c). Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release, 74, 47–61.
   PubMed Web of Science ®Google Scholar
• Maeda H. (2009a). Controlling oxidative stress: therapeutic and delivery strategies. Preface. Adv Drug Deliv Rev, 61, 285–286.
   PubMed Web of Science ®Google Scholar
• Maeda H, Bharate GY, Daruwalla J. (2009b). Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm, 71, 409–419.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res, 46, 6387–6392.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Akaike T, Yoshida M, Goto S, Horie H, Maeda H. (1996). Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors. Proc Soc Exp Biol Med, 211, 366–373.
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer RM, Higgs EA. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev, 43, 109–142.
   PubMed Web of Science ®Google Scholar
• Nishide H, Mihayashi K, Tsuchida E. (1977). Dissociation of aggregated ferroheme complexes and protoporphyrin IX by water-soluble polymers. Biochim Biophys Acta, 498, 208–214.
   PubMed Web of Science ®Google Scholar
• Oates JA, Brown NJ. (2001). Antihypertensive agents and the drug therapy of hypertension. In: Hardman JG, Limbird LE, Gilman AG, (eds.).Goodman & Gilman’s the pharmacological basis of therapeutics (10th Edition), The McGraw-Hill Companies, Inc., New York. pp. 871–896.
   Google Scholar
• Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, Maeda H. (1989). Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science, 244, 974–976.
   PubMed Web of Science ®Google Scholar
• Ogino T, Inoue M, Ando Y, Awai M, Maeda H, Morino Y. (1988). Chemical modification of superoxide dismutase. Extension of plasma half life of the enzyme through its reversible binding to the circulating albumin. Int J Pept Protein Res, 32, 153–159.
   PubMedGoogle Scholar
• Otsuka H, Nagasaki Y, Kataoka K. (2003). PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev, 55, 403–419.
   PubMed Web of Science ®Google Scholar
• Pacher P, Nivorozhkin A, Szabó C. (2006). Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev, 58, 87–114.
   PubMed Web of Science ®Google Scholar
• Radi R, Beckman JS, Bush KM, Freeman BA. (1991). Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem, 266, 4244–4250.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Sawa T, Fang J, Tanaka S, Miyamoto Y, Akaike T, Maeda H. (2002). Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity. Bioconjug Chem, 13, 1031–1038.
   PubMed Web of Science ®Google Scholar
• Stocks SJ, Jones AJ, Ramey CW, Brooks DE. (1986). A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol. Anal Biochem, 154, 232–234.
   PubMed Web of Science ®Google Scholar
• Veronese FM, Largajolli R, Boccù E, Benassi CA, Schiavon O. (1985). Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase. Appl Biochem Biotechnol, 11, 141–152.
   PubMed Web of Science ®Google Scholar
• Veronese FM, Schiavon O, Pasut G, Mendichi R, Andersson L, Tsirk A, Ford J, Wu G, Kneller S, Davies J, Duncan R. (2005). PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Bioconjug Chem, 16, 775–784.
   PubMed Web of Science ®Google Scholar
• Vicent MJ, Duncan R. (2006). Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol, 24, 39–47.
   PubMed Web of Science ®Google Scholar